ArticleFrontiers in medicine2026
Differential diagnosis model for tuberculous and malignant pleural effusion combining U-Net automatic segmentation and deep learning.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: We aimed to construct and validate an intelligent differential diagnosis model that integrates U-Net-based automatic segmentation with a deep learning classification model, and to evaluate its diagnostic performance and clinical value for distinguishing tuberculous pleural effusion (TPE) from malignant pleural effusion (MPE). Methods: A total of 281 patients with pleural effusion confirmed by etiological or pathological evidence between January 2018 and August 2025 were included, comprising 143 patients with TPE and 138 with MPE. First, a U-Net model was employed to automatically segment pleural lesion regions on chest computed tomography (CT) images and extract regions of interest (ROIs). Subsequently, based on the segmentation results, a radiomics model, a two-dimensional deep learning (DL2D) model, and a comprehensive model integrating clinical features were constructed. Multiple machine learning algorithms, including support vector machines (SVMs), random forests (RFs), and extremely randomized trees (ERTs), were utilized for model construction and comparison. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC), sensitivity, specificity, calibration curves, decision curve analysis (DCA), and the integrated discrimination improvement (IDI) and net reclassification improvement (NRI) indices. Results: The U-Net segmentation model achieved Dice coefficients of 0.873 and 0.862 in the training and test sets, respectively, indicating good segmentation performance. In the test set, the comprehensive model demonstrated the best performance, with an AUC of 0.934 (95% CI 0.8733-0.9955), sensitivity of 0.875, and specificity of 0.900. Its performance was superior to that of the clinical model (AUC = 0.767), the radiomics model (AUC = 0.841), and the DL2D model (AUC = 0.776). DCA confirmed that the comprehensive model provided a higher net clinical benefit across a wide range of threshold probabilities. Furthermore, IDI and NRI analyses indicated that the comprehensive model significantly improved predictive performance relative to the individual models ( Conclusion: The model combining U-Net-based automatic segmentation with a deep learning classification model exhibited excellent and balanced diagnostic performance for differentiating TPE from MPE. It has the potential to provide an objective, stable, and scalable intelligent decision-support tool for clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.